Showing posts with label GlaxoSmithKline. Show all posts
Showing posts with label GlaxoSmithKline. Show all posts

Monday, November 22, 2010

Red Wine as Effective as Popular Drug in Fight Against Type II Diabetes

Drinking a small glass of red wine every day can help treat diabetes, research has found.

Potent “super-food” compounds found in the wine can work as well as a daily dose of medication for people with Type 2 diabetes.

The discovery will come as welcome news to the 2.5 million people in Britain suffering from this form which can cause strokes, heart attacks and blindness.

Scientists discovered antioxidants in red wine can be just as effective as a daily dose of a combative drug.

The polyphenols – biologically active compounds in the wine – operate in a similar way to the drug rosiglitazone which is now banned.

The research was carried out before the ban came into effect.

Experts from Vienna’s University of Natural Resources and Applied Life Sciences found that a 125ml glass each day was enough to provide people with Type 2 diabetes with their daily dose of medication.

As well as the 2.5 million sufferers, a million more are thought to be living undiagnosed with the condition. Type 2 diabetes normally develops in middle age as a result of obesity or an unhealthy lifestyle.

The scientists, whose study is published in the Royal Society of Chemistry journal Food and Function, said the recommended daily dose for treating Type 2 diabetes using rosiglitazone is between 4mg and 8mg.

The team said 100ml of the tested red wines was equivalent to 1.8-18mg of rosiglitazone. It adds to the mounting evidence about the health benefits of a glass or two of red wine.

Rosiglitazone, also known as Avandia and made by GlaxoSmithKline, was taken by 100,000 people in the UK until it was recently banned because of increased risk of heart problems.

But Dr Iain Frame, director of research at Diabetes UK, said: “It is very difficult to see how this limited research will have any benefit to people with Type 2 diabetes. It is a basic study into the chemistry of red wine and has no clinical relevance at this stage. The researchers have made an astonishingly bold suggestion.”

Cheers! Here's to good health

- One 175ml glass a day can lower the risk of heart attack, helping to open blood vessels to prevent clots forming

- It also gives the daily required dose of iron (10mg for men, 15mg for women) and can help bone density in both sexes.

- Red wine has also been shown to preserve eyesight - a compound called reservatrol protects against the formation of damaged blood vessels which can cause blindness

- It can also protect against cancer due to the high polyphenol content in red grape skins

- Research indicates that moderate red wine consumption can have a positive effect on cholesterol levels and blood pressure, the so-called “French” effect

From: http://www.express.co.uk/posts/view/212962/How-red-wine-fights-diabetes

Helpful Links:

Boost Cellular Energy With D-Ribose

Reverse Memory Loss With Vinpocetine

Pregnenolone: The Happiness Hormone

DMG: The Anti-Aging Nutrient of the 21st Century

Boost Sexual Libido With Maca Root

CMO: The 30-Day Arthritis Pain Cure

Hoodia: Eliminates Hunger Pang All Day Long

Jubilee 3: Repairing Arthritic Joints, Naturally

Colloidal Silver Kills Viruses

Colloidal Silver Cures MRSA

Colloidal Silver Secrets blog

Colloidal Silver Secrets Group on Facebook

The Authoritative Guide to Vaccine Legal Exemptions

Meet Steve Barwick

Wednesday, September 1, 2010

India halts HPV vaccine testing after six girls die, yet US does nothing in response to 67 American deaths and counting…

The horrors caused by Merck & Co.'s Gardasil vaccine and GlaxoSmithKline's Cervarix vaccine continue as six young girls recently died from the shots during an experimental Indian trial.

The two human papillomavirus (HPV) vaccines have been implicated in at least 67 deaths in the U.S., prompting no response from U.S. officials other than to keep pushing it on the public, but the six deaths in India have prompted the government there to immediately stop all trials of the vaccines.

"Two imported brands of the human papillomavirus (HPV) vaccines, namely Gardasil and Cervarix, were allowed to undergo clinical trial (Phase III) in India, before being granted permission for import and market authorization," explained S. Gandhiselvan, minister of state for healthy and family welfare, in a statement to India's parliament.

However, because of the deaths, he advised all states to stop vaccinating immediately.

According to reports, the trials were wholly unethical and illegitimate to begin with, and were nothing more than blatant exploitation by drug companies of disadvantaged people from a developing nation.

Since many women in the industrialized world are now learning about the dangers of HPV vaccinations and rejecting them, Big Pharma has moved on to other populations in its quest to jab the entire world with the dangerous shots.

TruthAboutGardasil.org, a website devoted to exposing the true dangers associated with HPV vaccinations, also explains that drug companies are falsely advertising the vaccines in other counties, even going so far as to falsely claim that they are mandatory in the U.S., France and Australia.

"We consider this a human rights violation, and request the U.S. to take the lead in protecting fundamental human rights by calling for a congressional hearing," said Rosemary Mathis from TruthAboutGardasil.org.

However, there have been 67 U.S. deaths from HPV vaccinations reported thus far in the Vaccine Adverse Event Report System (VAERS), and countless reports of serious, life-damaging side effects, and officials have done nothing about it.

So it is unlikely that the U.S. will do anything to stop the poison from being marketed around the world as a cure.

From our good friends at NaturalNews.com -- http://www.naturalnews.com/029632_India_HPV_vaccine.html

Saturday, February 27, 2010

FDA allows another drug company to continue indiscriminately killing people...

Opinion: Once again we see the FDA’s almost unbelievable bias being played out on behalf of the major pharmaceutical companies.


Even when people are dropping like flies from a particular FDA-approved prescription drug – as in the case below where the diabetes drug Avandis is apparently causing some 500 heart attacks and 300 cases of heart failure every month – the FDA does nothing.

Yet the FDA continually screams from the high heavens that they need more authority to regulate nutritional supplements. They want to control supplement dosage levels. They want to control what information supplement manufacturers can and can’t tell the public. They want to control which supplement ingredients can be sold and which can’t. All of this, even though nutritional supplements have not caused a single death in the latest reporting period, while properly prescribed, FDA-approved prescription drugs kill an average of 106,000 people a year!


To the FDA, I say: No, thank you! Leave my supplements alone! You’re ‘regulation’ is unwanted and unneeded. Clean up your own house first, before you come into the nutritional supplement community to tell us our porch is dirty.


I’ve got nothing against prescription drugs. If you want to use them, go ahead. But it’s my choice to take nutritional supplements instead of drugs, whenever possible. And if there are consequences to my use of nutritional supplements instead of drugs, well, that’s my problem. I’ll deal with it.


Meanwhile FDA: Clean up your act before you start trying to cast stones at nutritional supplements!


-- Spencer



GlaxoSmithKline deliberately hid evidence of Avandia harm, says Senate report

Tuesday, February 23, 2010

by Mike Adams, the Health Ranger

Editor of NaturalNews.com

(NaturalNews) GlaxoSmithKline, maker of the diabetes drug Avandia, knew the drug was linked to tens of thousands of heart attacks but went out of its way to hide this information from the public, says a 334-page report just released by the Senate Finance Committee. (http://finance.senate.gov/press/Gpr...)

This report also accuses the FDA of betraying the public trust, explaining that FDA bureaucrats intentionally dismissed safety concerns found by the agency's own scientists.

The report says that Big Pharma's drugs "put public safety at risk because the FDA has been too cozy with drug makers and has been regularly outmaneuvered by companies that have a financial interest in downplaying or under-exploring potential safety risks." Sales of Avandia were $3.2 billion (yes, billion) in 2006.

According to a statistical analysis in the report, if all the diabetics currently taking Avandia were put on a "safer" drug, it would avert 500 heart attacks and 300 cases of heart failure every month in the United States alone. Presently, hundreds of thousands of Americans are still taking this drug, and hundreds will continue to die each month as a result, according to the report estimates.

This report, championed by U.S. Senators Grassley and Baucus, is the result of investigators pouring through more than 250,000 pages of documentation gathered from GlaxoSmithKline and the FDA. The document reveals some rather startling facts about the dangers of Avandia, including evidence from the FDA's own scientists who concluded that Avandia was associated with 83,000 heart attacks.

GlaxoSmithKline intimidates scientists

This investigative report also reveals that GSK engaged in the intimidation of physicians, saying: "GSK executives attempted to intimidate independent physicians, focused on strategies to minimize or misrepresent findings that Avandia may increase cardiovascular risk and sought ways to downplay findings that a competing drug might reduce cardiovascular risk."

"Patients trust drug companies with their health and their lives, and GlaxoSmithKline abused that trust." said Sen. Baucus. (Gee, really? Is anyone really surprised that GSK put its own financial interests ahead of a few thousand human lives?)

A separate letter sent to FDA Commissioner Margaret Hamburg by Senators Baucus and Grassley added, "the totality of evidence suggests that GSK was aware of the possible cardiac risks associated with Avandia years before such evidence became public."

The FDA's own research also showed Avandia to be associated with a significant increase in heart attack risk, yet the FDA did nothing to protect the public. The agency's own scientists wrote in 2008, "There is strong evidence that rosiglitazone [Avandia] confers an increased risk of [heart attacks] and heart failure compared to pioglitazone [a rival drug on market]." This evidence went completely ignored at the FDA.

The FDA's famous Dr David Graham -- the key whistleblower on the Vioxx scandal -- concluded from his own research, "Rosiglitazone should be removed from the market."

Even the American Medical Association -- a long-time defender of Big Pharma's drugs -- admitted Avandia was dangerous. Its journal, JAMA, wrote in 2007: "Among patients with impaired glucose tolerance or type 2 diabetes, rosiglitazone use for at least 12 months is associated with a significantly increased risk of myocardial infarction and heart failure, without a significantly increased risk of cardiovascular mortality."

The New England Journal of Medicine also warned about the safety of the drug in an article published in 2007.


Despite these multiple warnings, an FDA panel voted 22 - 1 in favor of keeping Avandia on the market. This is no surprise, of course, to those who know how the FDA really operates (and where its priorities really lie).

Tuesday, January 12, 2010

Drug companies made false claims in order to induce panic and boost market for H1N1 vaccine...



The severity of the H1N1 outbreak was deliberately exaggerated by pharmaceutical companies that stood to make billions of dollars from a worldwide scare, a leading European health expert has claimed.

Wolfgang Wodarg, head of health at the Council of Europe, has accused the makers of vaccines for the virus of unduly influencing the World Health Organisation's (WHO) decision to declare a pandemic. He claims the threshold for declaring a pandemic was purposely lowered so that vaccine makers could take maximum financial advantage of a crisis that literally didn't exist.

Helpful Links:

The Authoritative Guide to Vaccine Legal Exemptions

Colloidal Silver Kills Viruses

Colloidal Silver Secrets blog

Colloidal Silver Cures MRSA

Make Your Own Colloidal Silver

The Colloidal Silver Secrets Video

The Ultimate Colloidal Silver Manual

The New Micro-Particle Colloidal Silver Generator

Secrets of Natural Healing blog

The Immune Manual

Underground Publications that Could Save Your Life

Unique Nutritional Supplements

Friday, January 8, 2010

How Big Pharma Profits From Fear

How Big Pharma Profits From Fear

By WC Douglass, MD

1-8-10


With Big Pharma raking in billions off swine flu fears, the last thing they need is a government handout.


Yet Uncle Sam is busy playing Daddy Warbucks with YOUR lunch money, helping Swiss drugmaker Novartis open a new vaccine plant in North Carolina. You've generously contributed around $700 million to help Novartis build their shiny new drug factory -- $220 million three years ago, and $486 million this year.


And I'll bet you didn't even get a thank-you card.


In return for this bad investment in a foreign company, the U.S. government gets the right to PURCHASE vaccine for 17 years. Not only that, but these vaccines will be created using a new and unproven biotech method that relies on dog kidneys instead of chicken eggs.


In other words, this plan really is a dog.


I'm a doctor, not an economist. But if this is someone's idea of stimulus, you do the math: The plant now employs 191 people making an average of $50,000 per year. At that rate, it would take around 75 years for the government money put into this joint to make its way back into our own economy.


Slice off a few years if you believe them when they say they'll ultimately employ 350 people when the plant is fully operational in 2013 -- in any case, it'll be decades before Americans ever see that cash again.


But don't worry -- I'm sure somewhere, a poor Swiss ski resort is hosting a group of free-spending Novartis executives.


Maybe they'll be joined by their yodeling friends at the World Health Organization. A report at World Net Daily says at least three of the WHO's top flu "experts" have financial ties to vaccine makers.


That sure explains a lot.


Meanwhile, anyone who doubts that money is the real driving force behind swine flu fears only needs to check out Business Week magazine.


A recent headline there tells whole story by itself: "How Big Pharma Profits from Swine Flu."


Careful there, Business Week. That kind of thinking would have gotten you branded a radical conspiracy theorist just a few months ago!


Just check out these big paydays off swine flu vaccine sales:


$1.7 billion for GlaxoSmithKline


$700 million for Novartis


$500 million for Sanofi-Aventis

Those figures are for the fourth quarter of 2009 alone -- analysts expect them to grab similar piles of cash for the first quarter of 2010 as everyone from President Obama to Santa Claus push these needless vaccines on you and your children.


Business Week also notes that vaccine sales are booming just in time: Patents on prescription drugs worth a combined $135 billion in annual sales are about to expire... with no new meds ready to replace them.


And that means you can expect another phony swine flu scare any moment now.


That's not the only sickening swindle. Keep reading for the latest on Tamiflu...


Hide and seek with Big Pharma


Get ready for some more flu funny business -- except you won't be laughing when you hear about this one.


Drug giant Roche is being accused of hiding key data from eight unpublished studies on its flu drug, Tamiflu... and, as a result, researchers now say there's no evidence that the drug can reduce the risk of flu complications such as pneumonia.

What are they hiding? Who knows -- but you don't lock the smartest and most attractive kids in the attic.


The Cochrane Collaboration tried to update their earlier review of the research -- but the company demanded a confidentiality agreement in exchange for access to those eight shady studies.


I'm thrilled to say the researchers told Roche where to stick that agreement. Too bad that kind of integrity is all too rare.


In an editorial that accompanied the new review in the British Medical Journal, editor Fiona Godlee tore into the company. She wrote that the studies originally used to back Tamiflu were written by Roche employees and consultants, and that one researcher named in a study even claimed no involvement in the project.


Shady? You bet. Surprising? Not at all.


It's par for the course when it comes to Big Pharma.


So here's about all those researchers can say about Tamiflu now: It could reduce flu symptoms by about a day.


And here's what I can tell you about this dangerous drug: Its side effects include nausea, vomiting, stomach pain and diarrhea. Some patients experience severe allergic reactions, confusion, bizarre behavior, hallucinations, seizures, fever, sore throat and more.


Some of these reactions are far more common than anyone wants to admit -- especially in children, as I've warned you before.


htttp://clicks.douglassreport.com//t/AQ/wis/yBo/AAEZ2A/Ag/AuOyAg/Xppn


Worth it? You decide -- but I think you're better off investing in another box of tissues and that extra day of rest.


Never feeding the flu fears,

William Campbell Douglass II, M.D.



Helpful Links:

Unique Nutritional Supplements

The Immune Manual

Underground Publications that Could Save Your Life

The Authoritative Guide to Vaccine Legal Exemptions

Colloidal Silver Secrets blog

Colloidal Silver Kills Viruses

Colloidal Silver Cures MRSA

Make Your Own Colloidal Silver

The Colloidal Silver Secrets Video

The Ultimate Colloidal Silver Manual

The New Micro-Particle Colloidal Silver Generator

Secrets of Natural Healing blog